SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
From the Blogosphere
ImmunoGen’s Second License to Amgen (IMGN, AMGN)
|
|
|
ImmunoGen, Inc. (NASDAQ:IMGN) has announced that Amgen, Inc. (NASDAQ:AMGN)Inc has licensed the exclusive right to use ImmunoGen’s maytansinoid Targeted Antibody Payload (TAP) technology for the development of anticancer therapeutics to an undisclosed ...
|
Molson Coors Sudsy Disclosure
|
Molson Coors (TAP) came out with a sudsy press release and made some very interesting comments. The lawyers must have signed off and let the marketing people have a few. The verbiage is meaningless but designed to impress investors. Here is the snip
“We remain focused on building a diverse portfolio of extraordinary brands, offering value-enhancing innovations for consumers, and achieving positive pricing to grow our top-line and bottom-line as the economy improves. We offer value to consumers in many forms, including innovative brands and promotional packaging, as well as category-leading a< />< />< />< />< />< />< />< />< />< />< /><>< />...
|
Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
The Trading Radar highlights key earnings and economic announcements for tomorrow's trading session:<u>Before Market Opens:</u>Economics:7:30am ET- Challenger Job Cuts - no Street consensus
8:15am ET- ADP Employment Report - Street Sees (190K)
Earnings:3D Systems (NASDAQ: TDSC) – consensus loss $0.04Agilysys, Inc. (NASDAQ: AGYS) – consensus loss $0.19Agrium Inc. (NYSE: AGU) – consensus EPS $0.16Almost Family (NASDAQ: AFAM) – consensus EPS $0.70Alvarion (NASDAQ: ALVR) – consensus loss $0.02Ambac Financial Group (NYSE: ABK) – consensus loss $4.43American States Water (NYSE: AWR) – consensus EPS $0....
|
Amgen to Use ImmunoGen
|
The deal allows Amgen exclusive rights to use ImmunoGenÂ?s maytansinoid targeted antibody payload (TAP) technology for developing anticancer therapeutics.
|
Amgen to Use ImmunoGen
|
|
|
The deal allows Amgen exclusive rights to use ImmunoGenÂ?s maytansinoid targeted antibody payload (TAP) technology for developing anticancer therapeutics.
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Visit streetinsider.com
More Resources
|
About Molson Coors Brewing Company
- Answers.com
